Maze Therapeutics, Inc.
MAZE
$27.18
-$0.49-1.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.80% | 26.16% | -16.87% | -21.55% | -124.22% |
| Total Depreciation and Amortization | -39.75% | -35.09% | -29.22% | -27.54% | -24.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.93% | 98.35% | 23.35% | -27.01% | 48.25% |
| Change in Net Operating Assets | 1,941.91% | -1,561.47% | -130.16% | 109.58% | -142.73% |
| Cash from Operations | 49.91% | -32.51% | -23.51% | -6.19% | -120.72% |
| Capital Expenditure | 72.77% | 68.90% | 94.38% | 33.98% | -145.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -32,598.73% | 2,198.66% | -16,988.76% | -64,834.95% | -145.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,748.14% | -96.81% | 5,598.41% | 63,509.29% | 3,773.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 62.54% | -124.60% | 100.00% | 100.00% | -1,230.43% |
| Cash from Financing | 23,990.85% | -66.75% | -94.89% | 6,786.37% | 297.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.00% | -90.24% | -370.16% | 305.17% | -120.57% |